ONERA-HEALTH
5.9.2022 08:01:41 CEST | Business Wire | Press release
Onera Health, a leader in transforming sleep medicine and remote monitoring, announced today the official launch of its ground-breaking solution to diagnose sleep disorders in Europe. The service is based on the companies’ CE-marked and FDA-cleared Onera Sleep Test System and the Onera Digital Health Platform. It allows sleep professionals to conduct sleep studies at the comfort of the patients’ home while maintaining clinical-grade quality as with in-lab diagnostics.
Ruben de Francisco, Chief Executive Officer at Onera Health and one of the founders, explains: “For many years, comprehensive sleep diagnostics was mainly possible in in-patient laboratories that required significant resources, resulting in long waiting times and often poor patient experience. Our innovative solution enables large scale utilization of at-home polysomnography. This will not only increase patient comfort during a sleep study significantly, it will also improve access and shorten the diagnostic journeys of patients suffering from sleep disorders.”
“Sleep medicine struggled to keep up with the increasing prevalence of sleeping disorders for too long. Onera’s Polysomnography-as-a-Service solution allows to end delays in diagnosis, while at the same time ensuring a high-level of signal quality unseen in at-home sleep testing. This is especially important for patients with advanced or complicated sleep disorders”, adds Hartmut Schneider, MD, PhD, Chief Medical Officer and Onera Co-Founder.
Onera’s Polysomnography-as-a-Service solution will be offered in The Netherlands and Germany from 2022 onwards, with new countries in Europe being added over the next months.
The company will present new data of ongoing clinical validation studies around the Onera STS (Sleep Test System) at the 2022 ERS International Congress and exhibit its ground-breaking solution at booth #J02A, at the Fira Gran Via Convention Center Barcelona. The ERS International Congress is one of the largest medical conferences, bringing together a global audience of clinicians, scientists and researchers in the field of respiratory and sleep medicine.
Details of Onera’s abstract and poster presentation are as follows:
Title Overnight oxygen saturation is higher at the forehead compared to fingertip measurements
Date Monday, September 5, 2022, at 8:30-9:30 am CET
Poster Board Number PA2088
Authors Schneider H., Mukasa S., Mueller S., Varavinova A., Fronek F., Raschellà F, Ermers P., Vliexs M., De Francisco R.
About Onera
Onera Health is a leader in transforming diagnostics and monitoring. Their breakthrough products and technologies are poised to help millions of people struggling with health ailments and chronic conditions in a variety of medical fields, including sleep, neuro, cardiac and respiratory care, ultimately improving the health and quality of life for patients around the world. The company’s innovative solutions provide comprehensive physiological and health-related data to physicians in a variety of clinical and non-clinical environments to optimize patient care and reduce healthcare costs. Onera has offices in the Netherlands and the US. For more information, go to www.onerahealth.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220903005001/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting styrker sit udbud inden for digital transformation med Aesys2.3.2026 04:19:00 CET | Pressemeddelelse
Andersen Consulting annoncerer en samarbejdsaftale med den italienske virksomhed Aesys og udbygger dermed sine kompetencer inden for teknologi og systemintegration. Aesys blev stiftet i 2013 og er en virksomhed inden for digital teknologi og systemintegration, der leverer komplette it-løsninger. De kombinerer ekspertise inden for softwareudvikling, cloud computing, machine learning og cybersikkerhed med en stærk historik inden for systemintegration til bank- og bilindustrien og hjælper organisationer med at accelerere deres digitale transformation og forstærke deres teknologiske infrastruktur. "Med dette samarbejde kan vi skabe endnu større værdi for kunderne ved at kombinere vores dybe ekspertise inden for systemintegration med Andersen Consultings globale platform," udtaler Samuel Roberto, international business manager hos Aesys. "Sammen vil vi hjælpe organisationer med at styrke deres teknologiske fundament, implementere innovative løsninger inden for områder som machine learning o
GIGABYTE Powers Telecom AI Transformation with End-to-End Infrastructure at MWC 20262.3.2026 02:00:00 CET | Press release
From AI factories and supercomputing to digital twins, cloud hosting, and edge AI, GIGABYTE enables telecommunications operators to turn network data into intelligence, automation, and new revenue streams. GIGABYTE Technology, a global leader known for its engineering excellence in high-performance computing and AI servers, extends its comprehensive end-to-end AI infrastructure portfolio designed specifically for the telecommunications industry at MWC 2026. GIGABYTE’s end-to-end product solutions enable operators to convert massive volumes of network data into intelligence, automation, and new revenue streams, as telecommunications networks evolve from data carriers into AI-powered digital platforms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260223386188/en/ GIGABYTE Powers Telecom AI Transformation with End-to-End Infrastructure at MWC 2026 From Network Data to AI Value: Building Telco’s AI Factory At the core of the t
Lenovo Unveils Adaptive AI PCs, Modular Concepts, and Lenovo Qira Rollout at MWC 20262.3.2026 00:01:00 CET | Press release
From modular business computing and glasses-free 3D to foldable gaming and system-level AI, Lenovo advances Smarter AI for All At MWC® 2026, Lenovo™ introduces a new generation of adaptive AI devices and forward-looking concepts designed for business professionals, creators, students, and gamers. Headlined by new modular PC architecture, a glasses-free 3D laptop concept, a foldable gaming handheld device, and the initial rollout of Lenovo Qira, Lenovo’s showcase reflects a broader shift in personal computing toward systems that adapt intelligently to people and their environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260301217460/en/ Across its portfolio, Lenovo continues to focus on delivering technology that is more personalized, proactive, and protected, while building a unified AI ecosystem that works naturally across devices. “The AI era will not be defined by a single device or application, but by intelligent
TVCMALL at MWC 2026: Leading Mobile Accessories Wholesale and Smarter Sourcing1.3.2026 07:00:00 CET | Press release
As MWC Barcelona 2026 highlights the growing role of AI, connectivity, and smarter technology systems, the mobile accessories market is entering a new phase defined by speed and complexity. Product categories continue to expand, designs and styles update faster, and retailers are expected to respond to market changes in shorter cycles. Keeping product lines up to date while managing sourcing efficiently has become a real challenge for retailers and distributors across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121405485/en/ TVCMALL at MWC 2026: Leading Mobile Accessories Wholesale and Smarter Sourcing At MWC Barcelona 2026, TVCMALL highlights its role as a leading one-stop mobile accessories wholesaler in Europe, with a clear focus on making wholesale and sourcing easier, faster, and more reliable. With more than 18 years of experience, TVCMALL works closely with 30+ leading retail partners across Europe, supp
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom